These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33968811)

  • 1. Firms' participation in the Swiss COVID-19 loan programme.
    Fuhrer LM; Ramelet MA; Tenhofen J
    Swiss J Econ Stat; 2021; 157(1):2. PubMed ID: 33968811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19: guaranteed Loans and Zombie Firms.
    Zoller-Rydzek B; Keller F
    CESifo Econ Stud; 2020 Dec; 66(4):322-364. PubMed ID: 34191927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Has previous loan rejection scarred firms from applying for loans during Covid-19?
    Cowling M; Liu W; Calabrese R
    Small Bus Econ (Dordr); 2022; 59(4):1327-1350. PubMed ID: 38624828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Green management, access to credit, and firms' vulnerability to the COVID-19 crisis.
    Aristei D; Gallo M
    Small Bus Econ (Dordr); 2023 Apr; ():1-33. PubMed ID: 38625207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lending relationships and a corporate liquidity shortage: Evidence from the COVID-19 shock in Japan.
    Tsuruta D
    MDE Manage Decis Econ; 2022 Mar; ():. PubMed ID: 35571608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lockdown, employment adjustment, and financial frictions.
    Lastauskas P
    Small Bus Econ (Dordr); 2022; 58(2):919-942. PubMed ID: 38624870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Credit constraints and the severity of COVID-19 impact: Empirical evidence from enterprise surveys.
    Zhang D; Sogn-Grundvåg G
    Econ Anal Policy; 2022 Jun; 74():337-349. PubMed ID: 35281616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Financing constraints and firm-level responses to the COVID-19 pandemic: International evidence.
    Khan SU
    Res Int Bus Finance; 2022 Jan; 59():101545. PubMed ID: 34580554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small firms and the COVID-19 insolvency gap.
    Dörr JO; Licht G; Murmann S
    Small Bus Econ (Dordr); 2022; 58(2):887-917. PubMed ID: 38624681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SME viability in the COVID-19 recovery.
    McCann F; McGeever N; Yao F
    Small Bus Econ (Dordr); 2023 Jan; ():1-22. PubMed ID: 38625252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of environmental financing constraints: a case study from Vietnam.
    Le LH; Pham ATH
    Environ Sci Pollut Res Int; 2022 Nov; 29(54):81234-81255. PubMed ID: 35732891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity and state dependence in firms' access to bank credit.
    Aristei D; Angori G
    Small Bus Econ (Dordr); 2022; 59(1):47-78. PubMed ID: 38624968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Firm Exit during the COVID-19 Pandemic: Evidence from Japan.
    Miyakawa D; Oikawa K; Ueda K
    J Jpn Int Econ; 2021 Mar; 59():101118. PubMed ID: 35702632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of green credit policy on the formation of zombie firms: evidence from Chinese listed firms.
    Chen R
    Environ Sci Pollut Res Int; 2022 Nov; 29(53):80669-80682. PubMed ID: 35725881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The moderating effect of liquidity on the relationship between sustainability and firms' specifics: Empirical evidence from indian manufacturing sector.
    Farhan NHS; Almaqtari FA; Hazaea SA; Al-Ahdal WM
    Heliyon; 2023 Apr; 9(4):e15439. PubMed ID: 37151661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sadder but Wiser: The Role of SARS Imprinting and Firms' Recovery During the COVID-19 Pandemic.
    Yao H; Wang J; Bo Q; Li M
    Front Psychol; 2022; 13():917337. PubMed ID: 35756304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Firm bankruptcies and start-up activity in Switzerland during the COVID-19 crisis.
    Eckert F; Mikosch H
    Swiss J Econ Stat; 2022; 158(1):6. PubMed ID: 35282408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fiscal Stimulus and Firms' Sales and Capital Expenditure During the Global Financial Crisis.
    Correa-Caro C; Medina L; Poplawski-Ribeiro M; Sutton B
    Comp Econ Stud; 2021; 63(3):489-535. PubMed ID: 34366561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of capital structure management in maintaining the financial stability of hotel firms during the pandemic-A global investigation.
    Thi Mai Nguyen L; Le D; Vu KT; Tran TK
    Int J Hosp Manag; 2023 Feb; 109():103366. PubMed ID: 36447774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of COVID-19 government support and its consequences for firm liquidity and solvency.
    Lalinsky T; Pál R
    Struct Chang Econ Dyn; 2022 Jun; 61():305-335. PubMed ID: 35317527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.